找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hodgkin Lymphoma; A Comprehensive Over Andreas Engert,Anas Younes Book 2020Latest edition Springer Nature Switzerland AG 2020 Hodgkin Lymph

[復(fù)制鏈接]
樓主: industrious
41#
發(fā)表于 2025-3-28 15:26:45 | 只看該作者
42#
發(fā)表于 2025-3-28 19:59:22 | 只看該作者
Treatment of Early Favorable Hodgkin LymphomaHodgkin lymphoma became highly curable with large radiotherapy fields but at the cost of high early and late toxicity resulting in reduced long-term survival. The successful introduction of multiagent chemotherapy in Hodgkin lymphoma made it possible to combine chemotherapy with radiotherapy in smal
43#
發(fā)表于 2025-3-29 02:30:54 | 只看該作者
Treatment of Early Unfavorable Hodgkin Lymphomatinal mass, extranodal disease, high ESR, or more than three or four nodal areas involved. In addition, selected stage IIB patients are also included in this risk group. The treatment for these patients is based on four cycles of ABVD chemotherapy followed by involved-field radiotherapy or a more ag
44#
發(fā)表于 2025-3-29 03:12:48 | 只看該作者
Treatment of Advanced-Stage Hodgkin Lymphomase within 5 years. Thus, remission rates in excess of 50% achieved with MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) were a major breakthrough in oncology when first seen over 40 years ago. Systematic searches for more effective regimens have replaced MOPP by ABVD (doxorubicin,
45#
發(fā)表于 2025-3-29 07:47:28 | 只看該作者
46#
發(fā)表于 2025-3-29 13:21:05 | 只看該作者
Pediatric Hodgkin Lymphomary driving force for this divergence over the last 15–20 years has been a desire to reduce the burden of treatment with particular reference to late effects. That reduction is being achieved primarily by limiting the amount of radiotherapy required to maintain excellent EFS rates. Titration of thera
47#
發(fā)表于 2025-3-29 17:38:14 | 只看該作者
48#
發(fā)表于 2025-3-29 23:47:26 | 只看該作者
49#
發(fā)表于 2025-3-30 02:02:26 | 只看該作者
Henrik Hjalgrim,Ruth F. Jarrettocesses; transition arrays between level ensembles (configurations, superconfigurations); effective temperatures of configurations, superconfigurations, and ions; charge-state distributions; radiative power losses and opacity. There are many numerical examples and comparisons with experiment present
50#
發(fā)表于 2025-3-30 07:48:01 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 08:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
诏安县| 吉安县| 福泉市| 平山县| 阿克| 大关县| 绥江县| 宁远县| 丰顺县| 隆子县| 蒙自县| 云和县| 博野县| 仁寿县| 炎陵县| 双鸭山市| 应用必备| 绥德县| 霍山县| 阳曲县| 内乡县| 临城县| 应城市| 井陉县| 邳州市| 儋州市| 保德县| 泰州市| 邻水| 合江县| 若尔盖县| 翁牛特旗| 安阳市| 贺州市| 夹江县| 那坡县| 仙游县| 蒙阴县| 江西省| 仙游县| 积石山|